|
Commerce ministry assures to review track & trace system on issues raised by industry
|
|
Suja Nair Shirodkar
April 30 , 2015
|
|
|
To dispel the fears of the exporters over the impending track and trace
system, the commerce ministry gave a sympathetic hearing to issues and
concerns raised by the industry in a meeting held this week in Delhi.
The ministry assured all the stakeholders that they would duly consider
their submissions and take up the matter with the higher ups.
Pharmaceuticals
Export Promotion Council of India (Pharmexcil) had been closely working
with the stakeholders to highlight and bring into the notice of the
department of commerce on the problems relating to certain provisions in
the track and trace system. Following the notification, the industry
had sought clarification on the primary packaging, the parent- child
relationship clause and also on the monocartons that has been mentioned
in the same.
The Directorate General of Foreign Trade (DGFT)
through a notification recently had issued the procedure for
implementation of the track and trace system for exports of pharma and
drug consignments. While the notification exempts requirement of barcode
labelling and data uploading on central portal for exports of the drugs
that were manufactured before April 1, 2015. It clearly states that
from July 1, 2015, all drugs that were manufactured on or after April 1,
2015 can be exported only if both the tertiary and secondary packaging
carries bar coding as applicable. It also insists that all the relevant
data as prescribed by DGFT should be uploaded on the central portal.
Dr
P V Appaji, director general of Pharmexcil, informed that the commerce
ministry was keen to address the ongoing issues so that the exporters
did not have any problems post implementation. “Keeping in mind all
their concerns the ministry expressed keen interest to sort out the
matter by reviewing the points as per their recommendation and take
appropriate decision. The ministry was very supportive in hearing the
industry out on this matter. While at the same time, they also took the
occasion to bring in more clarity to the whole issue as well so as to
ensure that there was no confusion or fear among the stakeholder on
this,” added Dr Appaji.
All the leading association from the
country including Indian Drug Manufacturers’ Association (IDMA),
representatives from big pharma companies like Dr Reddy’s, Glenmark,
Mylan, Sun Pharma, Sandoz, EMIL along with the members of the committee
of administration (CoA) of Pharmexcil were privy to this meet.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|